ArticleFrontiers in pharmacology2025
Successful rescue of a rare case of refractory shock due to multidrug toxicity: a case report.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This article reports the successful treatment experience of refractory shock, acidosis, hypoglycemia, and multi-organ failure after overdose of reserpine, enalapril, and metformin, and aims to provide a reference for the rescue of patients with such poisoning. Methods: A 58-year-old woman with sudden disturbance of consciousness, intractable shock, severe metabolic acidosis, hypoglycemia, and multiple organ dysfunction was urgently transferred to the ICU. The blood pressure could not be maintained after massive rehydration and a large dose of vasoactive drugs. The treatment plan was adjusted quickly after the diagnosis and treatment of medicine, nephrology, cardiology, respiratory, and other disciplines, such as high-dose vasoactive drugs, pressors, continuous blood purification, plasma exchange and hemoperfusion.
resultsThe dose of vasoactive drugs began to decrease after entering the ICU at 36 h, and the acidosis gradually improved after 46 h. After 72 h, the patient was conscious and was transferred to the general ward on the 9th day. Conclusion: The treatment of mixed drug poisoning involving reserpine, metformin, and enalapril is very challenging. When resuscitating patients with refractory shock caused by such poisoning, early supportive therapies should be started, including gastric lavage, cathartic use, acid correction, improved ventilation, blood purification, and hemodialysis when needed. Additionally, vasoactive drugs may be given without an upper dose limit, as long as side effects are carefully monitored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.